Literature DB >> 11376587

Benefits and limits of hepatic resection for gastric metastases.

S Ambiru1, M Miyazaki, H Ito, K Nakagawa, H Shimizu, H Yoshidome, Y Shimizu, N Nakajima.   

Abstract

BACKGROUND: The significance of hepatic resection for gastric metastases has been controversial.
METHODS: Forty consecutive patients undergoing hepatic resection for gastric metastases were reviewed to examine the benefits and the limits of hepatic resection using univariate and multivariate analyses.
RESULTS: The overall survival was 27% at 2 years, 18% at 5 years, and 11% at 10 years. Six patients survived more than 5 years. All of the 6 patients underwent anatomical hepatic resection more extensive than segmentectomy, with sufficient resection margin. There were recurrences in 31 patients, and 94% of the recurrences were in the remaining liver. Univariate analysis showed time of hepatic metastases (P = 0.0078) and resection margin (P = 0.024) as significant prognostic factors. Multivariate analysis indicated that only time of hepatic metastases was an independent prognostic factor that influenced survival.
CONCLUSIONS: These results suggest that in patients with synchronous metastases we should consider patient selection more strictly, and that in patients with metachronous metastases we should perform anatomical hepatic resection with sufficient resection margin.

Entities:  

Mesh:

Year:  2001        PMID: 11376587     DOI: 10.1016/s0002-9610(01)00567-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  56 in total

Review 1.  Liver resections in metastatic gastric cancer.

Authors:  Sid P Kerkar; Clinton D Kemp; Itzhak Avital
Journal:  HPB (Oxford)       Date:  2010-11       Impact factor: 3.647

Review 2.  Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines.

Authors:  Yasuhiro Kodera; Kazumasa Fujitani; Norimasa Fukushima; Seiji Ito; Kei Muro; Norifumi Ohashi; Takaki Yoshikawa; Daisuke Kobayashi; Chie Tanaka; Michitaka Fujiwara
Journal:  Gastric Cancer       Date:  2014-04       Impact factor: 7.370

3.  Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancer.

Authors:  Andreas Andreou; Luca Viganò; Giuseppe Zimmitti; Daniel Seehofer; Martin Dreyer; Andreas Pascher; Marcus Bahra; Wenzel Schoening; Volker Schmitz; Peter C Thuss-Patience; Timm Denecke; Gero Puhl; Jean-Nicolas Vauthey; Peter Neuhaus; Lorenzo Capussotti; Johann Pratschke; Sven-Christian Schmidt
Journal:  J Gastrointest Surg       Date:  2014-08-27       Impact factor: 3.452

Review 4.  Strategies for treating liver metastasis from gastric cancer.

Authors:  Yoshihiro Kakeji; Masaru Morita; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

5.  Radical gastrectomy with hepatoarterial catheter implantation for late-stage gastric cancer.

Authors:  Guo-Liang Yao; Yong-Gang Fan; Jing-Ming Zhai; Bao-Sai Lu; Kai-Long Liu
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

6.  Surgery for liver metastasis from gastric cancer.

Authors:  Guido Alberto Massimo Tiberio; Franco Roviello; Annibale Donini; Giovanni de Manzoni
Journal:  Transl Gastroenterol Hepatol       Date:  2016-09-08

7.  Long-term survival after surgical resection for liver metastasis from gastric cancer: two case reports.

Authors:  Jong Keun Lim; Joong Bae Ahn; Sung Ha Cheon; Hyun Chang; Jong Yul Jung; Sun Young Rha; Jae Kyung Roh; Sung Hoon Noh; Ho Geun Kim; Hyun Cheol Chung; Hei-Cheul Jeung
Journal:  Cancer Res Treat       Date:  2006-06-30       Impact factor: 4.679

8.  High survival in patients operated for small isolated liver metastases from gastric cancer: a multi-institutional study.

Authors:  Koji Komeda; Michihiro Hayashi; Shoji Kubo; Hiroaki Nagano; Takuya Nakai; Masaki Kaibori; Hiroshi Wada; Shigekazu Takemura; Masahiko Kinoshita; Chikato Koga; Masataka Matsumoto; Tatsuma Sakaguchi; Yoshihiro Inoue; Fumitoshi Hirokawa; A-Hon Kwon; Kazuhisa Uchiyama
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

9.  Weekly docetaxel and cisplatin plus fluorouracil as a preoperative treatment for gastric cancer patients with synchronous multiple hepatic metastases: a pilot study.

Authors:  Zi-Yu Li; Lei Tang; Lian-Hai Zhang; Zhao-De Bu; Ai-Wen Wu; Xiao-Jiang Wu; Xiang-Long Zong; Qi Wu; Fei Shan; Shuang-Xi Li; Hui Ren; Xiao-Peng Zhang; Jia-Fu Ji
Journal:  Med Oncol       Date:  2009-12-05       Impact factor: 3.064

10.  Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer.

Authors:  Kentaro Ueda; Makoto Iwahashi; Mikihito Nakamori; Masaki Nakamura; Teiji Naka; Koichiro Ishida; Toshiyasu Ojima; Hiroki Yamaue
Journal:  Langenbecks Arch Surg       Date:  2008-03-15       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.